Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 22 tags : Disease save search
Ocuphire’s APX3330 for Retinal Diseases to be Presented at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting
Published: 2021-04-22 (Crawled : 18:00) - biospace.com/
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: 0.64%
H: 7.63%
C: 4.24%
disease retina research apx3330
Axcella Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021
Published: 2021-04-22 (Crawled : 18:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 0.0%
H: 2.34%
C: 0.0%
presentation disease
Akari Therapeutics Announces Poster Presentation of Phase II Bullous Pemphigoid Disease and Phase III Trial Design at American Academy of Dermatology Association Virtual Meeting Experience
Published: 2021-04-22 (Crawled : 12:00) - globenewswire.com
AKTX | $1.11 -8.26% -9.01% 3.7K
|
Health Technology
|
| O: 2.09%
H: 1.23%
C: -0.41%
presentation disease trial designation
Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
Published: 2021-04-22 (Crawled : 12:00) - biospace.com/
APM | $5.9 9.87% 8.98% 37K
|
Health Technology
|
| O: 4.45%
H: 5.43%
C: -1.94%
disease potential license
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.